Go Pro

AMN Healthcare Services (AMN) Competitors

AMN Healthcare Services logo
$34.20 +0.01 (+0.04%)
Closing price 03:59 PM Eastern
Extended Trading
$34.14 -0.06 (-0.19%)
As of 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

AMN vs. EYE, MEDP, VEEV, WST, and LFST

Should you buy AMN Healthcare Services stock or one of its competitors? AMN Healthcare Services's main competitors and comparable companies include National Vision (EYE), Medpace (MEDP), Veeva Systems (VEEV), West Pharmaceutical Services (WST), and LifeStance Health Group (LFST). Companies are selected based on similarities in market, industry, and size.

How does AMN Healthcare Services compare to National Vision?

AMN Healthcare Services (NYSE:AMN) and National Vision (NASDAQ:EYE) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, institutional ownership, valuation, risk, analyst recommendations, profitability, dividends and earnings.

National Vision has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.76
National Vision$1.99B0.63$29.60M$0.6125.98

AMN Healthcare Services has a net margin of 3.06% compared to National Vision's net margin of 2.47%. AMN Healthcare Services' return on equity of 19.92% beat National Vision's return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
National Vision 2.47%6.78%3.01%

In the previous week, AMN Healthcare Services had 6 more articles in the media than National Vision. MarketBeat recorded 12 mentions for AMN Healthcare Services and 6 mentions for National Vision. National Vision's average media sentiment score of 0.97 beat AMN Healthcare Services' score of 0.54 indicating that National Vision is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
National Vision
4 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AMN Healthcare Services presently has a consensus target price of $36.00, indicating a potential upside of 5.25%. National Vision has a consensus target price of $29.82, indicating a potential upside of 88.13%. Given National Vision's stronger consensus rating and higher probable upside, analysts clearly believe National Vision is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
National Vision
0 Sell rating(s)
4 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.64

AMN Healthcare Services has a beta of 0.38, indicating that its share price is 62% less volatile than the broader market. Comparatively, National Vision has a beta of 0.98, indicating that its share price is 2% less volatile than the broader market.

99.2% of AMN Healthcare Services shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by insiders. Comparatively, 2.4% of National Vision shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Summary

National Vision beats AMN Healthcare Services on 9 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Medpace?

AMN Healthcare Services (NYSE:AMN) and Medpace (NASDAQ:MEDP) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, profitability, media sentiment, valuation, institutional ownership, analyst recommendations, risk and dividends.

Medpace has a net margin of 17.67% compared to AMN Healthcare Services' net margin of 3.06%. Medpace's return on equity of 110.15% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
AMN Healthcare Services3.06% 19.92% 5.93%
Medpace 17.67%110.15%24.84%

In the previous week, AMN Healthcare Services had 1 more articles in the media than Medpace. MarketBeat recorded 12 mentions for AMN Healthcare Services and 11 mentions for Medpace. Medpace's average media sentiment score of 1.40 beat AMN Healthcare Services' score of 0.54 indicating that Medpace is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
AMN Healthcare Services
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive
Medpace
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

AMN Healthcare Services has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market. Comparatively, Medpace has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

Medpace has lower revenue, but higher earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Medpace, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.76
Medpace$2.53B6.84$451.12M$17.0636.37

AMN Healthcare Services currently has a consensus price target of $36.00, suggesting a potential upside of 5.25%. Medpace has a consensus price target of $595.20, suggesting a potential downside of 4.07%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, research analysts clearly believe AMN Healthcare Services is more favorable than Medpace.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
AMN Healthcare Services
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38
Medpace
0 Sell rating(s)
9 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.25

99.2% of AMN Healthcare Services shares are owned by institutional investors. Comparatively, 78.0% of Medpace shares are owned by institutional investors. 1.1% of AMN Healthcare Services shares are owned by company insiders. Comparatively, 20.5% of Medpace shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Medpace beats AMN Healthcare Services on 10 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to Veeva Systems?

Veeva Systems (NYSE:VEEV) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, valuation, media sentiment, dividends, analyst recommendations, institutional ownership and profitability.

Veeva Systems has a beta of 0.97, indicating that its stock price is 3% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, indicating that its stock price is 62% less volatile than the broader market.

Veeva Systems has a net margin of 29.34% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat Veeva Systems' return on equity.

Company Net Margins Return on Equity Return on Assets
Veeva Systems29.34% 14.25% 11.71%
AMN Healthcare Services 3.06%19.92%5.93%

In the previous week, Veeva Systems had 9 more articles in the media than AMN Healthcare Services. MarketBeat recorded 21 mentions for Veeva Systems and 12 mentions for AMN Healthcare Services. Veeva Systems' average media sentiment score of 1.03 beat AMN Healthcare Services' score of 0.54 indicating that Veeva Systems is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Veeva Systems
13 Very Positive mention(s)
4 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Veeva Systems has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than Veeva Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Veeva Systems$3.20B13.48$908.91M$6.0843.77
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.76

88.2% of Veeva Systems shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 10.6% of Veeva Systems shares are held by company insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Veeva Systems currently has a consensus target price of $284.88, suggesting a potential upside of 7.05%. AMN Healthcare Services has a consensus target price of $36.00, suggesting a potential upside of 5.25%. Given Veeva Systems' stronger consensus rating and higher possible upside, equities analysts plainly believe Veeva Systems is more favorable than AMN Healthcare Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Veeva Systems
1 Sell rating(s)
8 Hold rating(s)
19 Buy rating(s)
0 Strong Buy rating(s)
2.64
AMN Healthcare Services
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

Summary

Veeva Systems beats AMN Healthcare Services on 14 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

West Pharmaceutical Services has a net margin of 16.98% compared to AMN Healthcare Services' net margin of 3.06%. West Pharmaceutical Services' return on equity of 20.11% beat AMN Healthcare Services' return on equity.

Company Net Margins Return on Equity Return on Assets
West Pharmaceutical Services16.98% 20.11% 14.83%
AMN Healthcare Services 3.06%19.92%5.93%

In the previous week, West Pharmaceutical Services had 9 more articles in the media than AMN Healthcare Services. MarketBeat recorded 21 mentions for West Pharmaceutical Services and 12 mentions for AMN Healthcare Services. West Pharmaceutical Services' average media sentiment score of 0.79 beat AMN Healthcare Services' score of 0.54 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
West Pharmaceutical Services
12 Very Positive mention(s)
2 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

West Pharmaceutical Services currently has a consensus target price of $379.08, indicating a potential upside of 4.04%. AMN Healthcare Services has a consensus target price of $36.00, indicating a potential upside of 5.25%. Given AMN Healthcare Services' higher possible upside, analysts plainly believe AMN Healthcare Services is more favorable than West Pharmaceutical Services.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
West Pharmaceutical Services
0 Sell rating(s)
3 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.79
AMN Healthcare Services
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

West Pharmaceutical Services has higher revenue and earnings than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than West Pharmaceutical Services, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
West Pharmaceutical Services$3.07B8.34$493.70M$7.8146.65
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.76

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

West Pharmaceutical Services has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, meaning that its stock price is 62% less volatile than the broader market.

Summary

West Pharmaceutical Services beats AMN Healthcare Services on 13 of the 16 factors compared between the two stocks.

How does AMN Healthcare Services compare to LifeStance Health Group?

LifeStance Health Group (NASDAQ:LFST) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, dividends, risk, earnings, valuation and institutional ownership.

LifeStance Health Group presently has a consensus target price of $12.88, suggesting a potential downside of 1.42%. AMN Healthcare Services has a consensus target price of $36.00, suggesting a potential upside of 5.25%. Given AMN Healthcare Services' higher possible upside, analysts plainly believe AMN Healthcare Services is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73
AMN Healthcare Services
1 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.38

85.5% of LifeStance Health Group shares are held by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are held by institutional investors. 3.5% of LifeStance Health Group shares are held by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

LifeStance Health Group has a beta of 1.22, suggesting that its stock price is 22% more volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.38, suggesting that its stock price is 62% less volatile than the broader market.

LifeStance Health Group has a net margin of 3.19% compared to AMN Healthcare Services' net margin of 3.06%. AMN Healthcare Services' return on equity of 19.92% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
LifeStance Health Group3.19% 3.39% 2.33%
AMN Healthcare Services 3.06%19.92%5.93%

In the previous week, LifeStance Health Group had 5 more articles in the media than AMN Healthcare Services. MarketBeat recorded 17 mentions for LifeStance Health Group and 12 mentions for AMN Healthcare Services. LifeStance Health Group's average media sentiment score of 0.72 beat AMN Healthcare Services' score of 0.54 indicating that LifeStance Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
LifeStance Health Group
5 Very Positive mention(s)
1 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
AMN Healthcare Services
3 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

LifeStance Health Group has higher earnings, but lower revenue than AMN Healthcare Services. AMN Healthcare Services is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
LifeStance Health Group$1.42B3.50$9.66M$0.13100.46
AMN Healthcare Services$2.73B0.49-$95.70M$2.6812.76

Summary

LifeStance Health Group beats AMN Healthcare Services on 11 of the 17 factors compared between the two stocks.

Get AMN Healthcare Services News Delivered to You Automatically

Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AMN vs. The Competition

MetricAMN Healthcare ServicesHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$1.32B$9.99B$7.21B$23.26B
Dividend YieldN/A2.61%2.57%3.58%
P/E Ratio12.7633.86272.8428.40
Price / Sales0.495.01651.7520.41
Price / Cash4.12126.2577.7134.34
Price / Book2.055.3710.374.69
Net Income-$95.70M$313.45M$3.49B$1.07B
7 Day Performance1.31%-0.08%-2.20%-2.41%
1 Month Performance-0.76%-1.06%-0.38%-4.27%
1 Year Performance87.88%16.10%19.16%8.87%

AMN Healthcare Services Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
AMN
AMN Healthcare Services
1.8702 of 5 stars
$34.20
+0.0%
$36.00
+5.3%
+87.4%$1.32B$2.73B12.762,664
EYE
National Vision
4.2853 of 5 stars
$16.74
flat
$30.36
+81.4%
-23.8%$1.32B$1.99B27.4413,138
MEDP
Medpace
2.6626 of 5 stars
$591.29
flat
$595.20
+0.7%
+21.4%$16.50B$2.53B34.666,200
VEEV
Veeva Systems
4.3663 of 5 stars
$274.02
-0.4%
$284.46
+3.8%
-3.8%$44.54B$3.20B45.077,928
WST
West Pharmaceutical Services
2.9436 of 5 stars
$339.90
0.0%
$368.08
+8.3%
+40.3%$23.93B$3.07B43.5210,800

Related Companies and Tools


This page (NYSE:AMN) was last updated on 9/15/2026 by MarketBeat.com Staff.
From Our Partners